4
Changes in Ownership
SAB Biotherapeutics, Inc. Filed Acc 0001493152-21-026388
Chief Medical Officer acquired 6,418 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Luke Thomas Charles Chief Medical Officer | 2021-10-19 | Grant or award | +990 | $10.10 | $9,999 | 990 | D: show line 1 in the form |
| Luke Thomas Charles Chief Medical Officer | 2021-10-22 | Grant or award | +5,428 | 5,428 | D: show line 2 in the form |
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Luke Thomas Charles Chief Medical Officer | 2021-10-22 | Grant or award · Earnout Rights (Common Stock) | +2,193 | 2,193 | D: show line 3 in the form | ||
| Luke Thomas Charles Chief Medical Officer | 2021-10-22 | Grant or award · Employee Stock Option (right to buy) | +139,585 | 139,585 | D: show line 4 in the form | ||
| Luke Thomas Charles Chief Medical Officer | 2021-10-22 | Grant or award · Employee Stock Option (right to buy) | +11,632 | 11,632 | D: show line 5 in the form | ||
| Luke Thomas Charles Chief Medical Officer | 2021-10-22 | Grant or award · Earnout Rights (Restricted Stock Units) | +61,092 | 61,092 | D: show line 6 in the form |
Loading xslF345X03/ownership.xml…